Skip to content

UTERON PHARMA

Dissolved and wound up KBO/BCE: BE 0818.071.472 subsidiary of

Holdings

own 2018 accounts, the bar shows equity in euros
This companyUTERON PHARMA2 holdings, 1 country 2018 accounts

Belgium 2 Year Equity Result

  • BE 99.98% 2025€76.4m result €35.9m (2025)
  • BE 99.99%dissolved 2018-€9.3m result -€466,908 (2018)

Source: list of holdings in its own 2018 accounts. Every holding stands with its own latest accounts.

Parent

Ireland

Earlier ties

via (at UTERON PHARMA until 2018) and (at UTERON PHARMA until 2019) · deed of 14-10-2016
founded in 2007
62 FTE (2025)
via (at UTERON PHARMA until 2015), (at UTERON PHARMA until 2018) and (at UTERON PHARMA until 2019) · deeds of 14-10-2016 and 29-10-2015
Dissolved
total assets €595,602 (2018)
via , at UTERON PHARMA until 2016 · Permanent representative · deed of 29-10-2015
Dissolved
total assets €287,566 (2022)
via , at UTERON PHARMA until 2015 · Daily management delegate · deed of 02-09-2015
Dissolved

Holdings through the years

2010 to 2018
Holdings through the years
Name201020112012201320142015201620172018
99%99.99%
99.98%
70%99%99.99%
53%68%99%99.99%
0.1%
87.5%99%

Source: list of holdings in its own accounts

Connections & network

Depth
Shared director 3 shared directors 2 shared directors Shared corporate director UTERON PHARMA UTERONPHARMA0818.071.472
Shared directors
This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.